Bilastine - CAS 202189-78-4
Catalog number: 202189-78-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Histamine Receptor
Description:
Bilastine is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.99
Synonyms:
Bilastine, trade name Bilaxten
MSDS:
Inquire
1. Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans
Martin K. Church. Inflamm. Res. (2011) 60:1107–1112
Early clinical trials have also shown bilastine to be a potent and effective H1-antihistamine. In a study of 525 patients with chronic idiopathic urticaria, bilastine 20 mg once daily significantly (P<0.001 compared with pla- cebo) relieved the symptoms. Furthermore, the overall efficacy results demonstrated that bilastine was of similar efficacy to levocetirizine. In the nose, a double-blind cross-over study in which 75 allergic volunteers were challenged with grass pollen in the Vienna Challenge Chamber showed bilastine to be equally effective as cetirizine and fexofenadine but the results obtained suggest that it has a longer duration than fexofenadine, while in two 14-day trials in seasonal allergic rhinitis, bilastine was shown to be of similar efficacy to daily dosage with 10 mg cetirizine and 5 mg desloratadine.
2. Allergic Conjunctivitis and the Impact of Allergic Rhinitis
Leonard Bielory. Curr Allergy Asthma Rep (2010) 10:122–134
Antihistamines: Bilastine and Bepotastine Recent clinical data suggest an ocular and nasal allergy efficacy profile for bilastine, a new oral antihistamine, similar to that of established oral antihistamines, including desloratadine and cetirizine. In addition, another oral antihistamine agent, bepotastine, was shown to be effective and well-tolerated in patients with Japanese cedar allergen–induced symptoms in an exposure chamber and was recently approved in the United States in an ophthalmic formulation with a very similar profile to those of olopatadine and epinastine.
3. New Therapies for Allergic Rhinitis
Fulvio Braido & Francesca Sclifò & Matteo Ferrando & Giorgio Walter Canonica. Curr Allergy Asthma Rep (2014) 14:422
Bilastine, a new nonsedating H1 receptor inverse agonist, belongs to the piperidine class along with loratadine, desloratadine, and fexofenadine. In vitro studies have shown that bilastine has a high specific affinity for the H1 receptor but no or very low affinity for 30 other tested receptors. This affinity for the H1 receptor is three and six times higher than for cetirizine and fexofenadine, respectively. Bilastine behaves as an H1 mixed antagonist (competitive up to 33 nM; not competitive from 100 nM), as it is 5.5 times more powerful than cetirizine as a competitive antagonist and 10 times more powerful as a noncompetitive antagonist. The effectiveness of bilastine is comparable to that of desloratadine. Besides its H1 antagonism, bilastine has also demonstrated anti-inflammatory properties, including inhibiting the release of proinflammatory cytokines such as IL-4 and tumor necrosis factor-α. Furthermore, in vivo studies in rats demonstrated a significant reduction in histamine-stimulated endothelial permeability, microvascular extravasation, and inhibition of smooth muscular contraction and bronchospasm times that of cetirizine.
4. Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study
Valvanera Vozmediano • Ignacio Ortega • John C. Lukas • Ana Gonzalo • Monica Rodriguez • Maria Luisa Lucero. Eur J Drug Metab Pharmacokinet (2014) 39:33–41
First PK modeling was performed for the i.v. and p.o. data in animals alone. Two compartmental representations best described the kinetics of bilastine in animals. The results of Jauregizar et al. (2009) were applied for p.o. bilastine in man. The PK parameters for all species are listed in Table 3 (for p.o. in rat, dog and man and for i.v. in rat and dog). Table 3 also lists the protein binding fraction (fu) for bilastine in these three species.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 104076-39-3 Zolantidine dimaleate

Zolantidine dimaleate
(CAS: 104076-39-3)

Zolantidine dimaleate is a potent brain penetrating histamine H2 receptor antagonist.

CAS 108612-45-9 Mizolastine

Mizolastine
(CAS: 108612-45-9)

Mizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic r...

CAS 59-32-5 Halopyramine

Halopyramine
(CAS: 59-32-5)

Halopyramine is known as a competitive reversible H1-receptor antagonist. It exerts its pharmacological action by competing with histamine for the H1 subtype hi...

CAS 1082954-71-9 A 987306

A 987306
(CAS: 1082954-71-9)

A 987306 is a potent histamine H4 receptor antagonist (pKi = 8.24 and 8.47 in human and rat H4 receptors, respectively) with 162-, 620-, and > 1600-fold selecti...

CAS 118288-08-7 Lafutidine

Lafutidine
(CAS: 118288-08-7)

Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.

CAS 64-89-1 Propiomazine Hydrochloride

Propiomazine Hydrochloride
(CAS: 64-89-1)

Propiomazine Hydrochloride is an antihistamine blocking H1 receptors. It is used to treat insomnia and to produce drowsiness. It is also used to relieve anxiety...

CAS 459168-41-3 JNJ-7777120

JNJ-7777120
(CAS: 459168-41-3)

JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other h...

FR-A 19
(CAS: 141099-46-9)

FR-A 19 is a Histamine H2 receptor agonist with potent anti-allergic properties. It can inhibit IgE-mediated human basophil histamine release in a nanomolar ran...

CAS 10246-75-0 Hydroxyzine pamoate

Hydroxyzine pamoate
(CAS: 10246-75-0)

Hydroxyzine pamoate, a derivative of hydroxyzine, is a histamine H1-receptor antagonist that has been used as anxiolytic and antihistaminic so that it is probab...

CAS 1620-21-9 Chlorcyclizine hydrochloride (1:x)

Chlorcyclizine hydrochloride (1:x)
(CAS: 1620-21-9)

The hydrochloride salt form of Chlorcyclizine which could be used as an antihistamine agent and is also found to have anticholinergic effect at some extent.

CAS 149629-70-9 Impentamine dihydrobromide

Impentamine dihydrobromide
(CAS: 149629-70-9)

Impentamine dihydrobromide is the dihydrobromide salt of impentamine, which is a highly selective and the most potent histamine H3 antagonist with pA2 value of ...

CAS 142457-00-9 Amthamine dihydrobromide

Amthamine dihydrobromide
(CAS: 142457-00-9)

Amthamine dihydrobromide is the dihydrobromide salt of amthamine, which is a highly selective histamine H2 receptor agonist. It is a weak antagonist at H3 and h...

CAS 177708-09-7 Proxyfan oxalate

Proxyfan oxalate
(CAS: 177708-09-7)

Proxyfan oxalate is a high affinity histamine H3 receptor ligand (pKi = 8.62), acting as a protean agonist with activity ranges from full agonist to inverse ago...

CAS 184576-87-2 ROS 234 dioxalate

ROS 234 dioxalate
(CAS: 184576-87-2)

ROS 234 dioxalate is a potent H3 antagonist (pKB at guinea-pig ileum H3-receptor = 9.46).

CAS 84545-30-2 ICI 162,846

ICI 162,846
(CAS: 84545-30-2)

ICI 162,846 is a potent histamine H2 receptor antagonist.

CAS 85604-00-8 Zaltidine

Zaltidine
(CAS: 85604-00-8)

Zaltidine is an effective but hepatotoxic H2-receptor antagonist. It has higher incidence of hepatic damage than with commonly used H2-receptor antagonists. It ...

CAS 152241-24-2 GT 2016

GT 2016
(CAS: 152241-24-2)

GT 2016 is a high affinity and brain-penetrant histamine H3 receptor antagonist (Ki = 43.8 nM). It displays selectivity against H1 and H2 receptors (IC50 >10 μM...

KDM5A-IN-1
(CAS: 1905481-36-8)

KDM5A-IN-1, a pyrrolidine amide compound, is an inhibitor histone demethylases.

CAS 132-21-8 dexbrompheniramine

dexbrompheniramine
(CAS: 132-21-8)

Dexbrompheniramine is an histamine H1-receptor antagonist used for the treatment of allergic conditions including hay fever or urticaria. It is the pharmacologi...

CAS 720690-73-3 GSK 189254A

GSK 189254A
(CAS: 720690-73-3)

GSK-189,254 is a H3 histamine receptor inverse agonist. It has subnanomolar affinity for the H3 receptor with Ki of 0.2nM. It possesses stimulant and nootropic ...

Chemical Structure

CAS 202189-78-4 Bilastine

Quick Inquiry

Verification code

Featured Items